Oxigene Logo spacer
Learn More Graphic
Investors Graphic


Overview
Stock Quote
Executive Management
Corporate Governance
Annual Reports
SEC Filings
Press Releases
Investor FAQs
Events and Presentations
Contact Investor Relations
Request Printed Materials
Investor Alert Sign-up
 

OXiGENE is highly committed to delivering value to its shareholders. With a pipeline of high-potential therapeutic candidates that have demonstrated promising results to date in clinical trials, and a highly experienced management team, we're working to translate innovative science into important, next-generation therapeutic products that deliver significant medical benefits to patients suffering from cancer and eye disease.

OXiGENE is listed on the Nasdaq Global Market and the Stockholm Stock Exchange under the symbol "OXGN."

OXiGENE is headquartered in Waltham, Massachusetts and maintains drug development operations in South San Francisco, California.

 
Stock Quote Header
spacer

4:00 PM ET - 02/08/10

$1.24   ( 0.03)

Volume

135,700

Day High

1.25

Day Low

1.18

52-week High

2.78

52-week Low

0.52

» more


spacer
Stock Quote Bottom
spacer
Stock Quote Header
spacer spacer

Shareholder Briefcase

Download Library

RSS News Feeds

Search Investor Relations

 

spacer
Stock Quote Bottom